Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

By sjmartinez • November 3, 2022

Weitz JI, Szekanecz Z, Charles-Schoeman C, Vranic I, Sahin B, Paciga SA, Wang Z, Hyde C, Martin DA. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD Open. 2022 Nov;8(2):e002571. doi: 10.1136/rmdopen-2022-002571. PMID: 36323490.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, Publications, Rheumatoid, Rheumatology

Dupilumab for bullous pemphigoid: Umbrella review of systematic reviews and meta-analyses

Thapa M, Green B, Kasperkiewicz M. Dupilumab for bullous pemphigoid: Umbrella review of systematic reviews and meta-analyses. JAAD Int. 2025 Oct 18;24:172-176. doi: 10.1016/j.jdin.2025.10.004. PMID:[...]

Metabolic Acidosis in Chronic Alcoholism: When It’s Not Just Diabetic Ketoacidosis

Li R, Han J, Sidhu H. Metabolic Acidosis in Chronic Alcoholism: When It's Not Just Diabetic Ketoacidosis. Cureus. 2025 Nov 11;17(11):e96632. doi: 10.7759/cureus.96632. PMID: 41393585;[...]

Immunomodulatory Microneedle Patch for Cardiac Repair in Rodent and Porcine Models of Myocardial Infarction

Huang K, Zhu D, Soto J, Hu S, Fang J, Huang J, Zhang X, Li J, Li Y, Tasoudis P, Liu S, Mei X, Hoffman[...]